Hongquan Wan, DVM, PhD, Food & Drug Administration

Products

References

  1. Wan H, Yang H, Shore DA, Garten RJ, Couzens L, Gao J, Jiang L, Carney PJ, Villanueva J, Stevens J, Eichelberger MC. Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers. Nat Commun. 2015 Feb 10;6:6114.
  2. Hongquan W. Li Q. Gao J. Couzens LK. Lianlian J. Gao Y. Sheng ZM. Fong S. Hahn M. Surender K. Jeffery TK. Eichelberger MC. Comparison of the Efficacy of N9 Neuraminidase-Specific Monoclonal Antibodies against Influenza A(H7N9) Virus Infection. Journal of Virology. 2018 February. 92(4);e01588017.
  3. Hongquan W. Gao J. Xu K. Chen Hongjun. Couzens Lk. Rivers KH. Easterbrook JD. Yang K. Zhong L. Rajabi M. Jianqiang Y. Sultana I. Wan X, Liu X. Perez DR. Taubenberger JK. Eichelberger MC. Molecular Basis for Broad Neuraminidase Immunity: Conserved Epitopes in Seasonal and Pandemic H1N1 as Well as H5N1 Influenza Viruses. Journal of Virology. 2013 Aug 16;9290-9300.
  4. Hongquan W. Gao J. Yang H. Yang S. Harvey S. Chen Y. Zheng N. Chang J. Carney PJ. Li X. Plant E. Jiang Lianlian. Couzens L. Wang C. Strohmeier S, Wu WW. Shen RF. Krammer F. Cipollo JF. Wilso PC. Stevens J. Wan XF. Eichelberger MC. Ye Z. The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain. Nat Microbiol. 2019 December. 4(12);2216-2225.